Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Tofacitinib
Tofacitinib
477600-75-2
|
312.37
|
1.517
Tofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is used for the treatment of moderate to severe rheumatoid arthritis which is resistant or intolerant to methotrexate therapy. It may also be used as an adjunct to methotrexate therapy, or other non-biologic disease-modifying antirheumatic drugs, when methotrexate alone is not sufficient.
(+/-)-CP 690550 | Tofacitinib | tasocitinib | tofacinib | xeljanz
Tofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is used for the treatment of moderate to severe rheumatoid arthritis which is resistant or intolerant to methotrexate therapy. It may also be used as an adjunct to methotrexate therapy, or other non-biologic disease-modifying antirheumatic drugs, when methotrexate alone is not sufficient.
(+/-)-CP 690550 | Tofacitinib | tasocitinib | tofacinib | xeljanz
$48/5 mg
(EBC)
1
CAS:540737-29-9
0
CAS:
0
CAS:477600-75-2
0
We provide 0 compound for Tofacitinib